KDM5B and breast cancer: Our finding that H3K4me3 decreases in response to Tat-SID-mediated disruption of KDM5B is in agreement with recent studies in which KDM5B has been knocked down in embryonic stem cells [47] or breast cancer cell lines [30, 48], as well as in a mouse knockout model [49].